Lv11
40 积分 2024-11-24 加入
LBA-13 Real-World Efficacy of Anti-CD38 (Daratumumab)-Based Regimens and Long-Term Outcomes in Transplant-Eligible Multiple Myeloma: A 10-Year Tunisian Cohort Study
4小时前
已关闭
Efficacy and Safety of Camrelizumab Combined with Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Phase II Single-Arm Clinical Trial
1个月前
已完结
Efficacy and Safety of Camrelizumab Combined with Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Phase II Single-Arm Clinical Trial
2个月前
已完结
【Supplementary material】Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
2个月前
已关闭
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
2个月前
已完结
皖公网安备34019202002308
